DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tyrosine kinase 2
Tyrosine kinase 2
Erb‑B2 Receptor Tyrosine Kinase 2 Is Negatively Regulated by the P53‑Responsive Microrna‑3184‑5P in Cervical Cancer Cells
JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors
Biomarker Testing in Non- Small Cell Lung Cancer (NSCLC)
Targeting the Function of the HER2 Oncogene in Human Cancer Therapeutics
Kinase-Targeted Cancer Therapies: Progress, Challenges and Future Directions Khushwant S
Hepatocyte Growth Factor Receptor (C-Met)/Fc Chimera Human
Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia
Hirbe AC, Kaushal M, Sharma MK
Trastuzumab Mechanism of Action; 20 Years of Research to Unravel a Dilemma
Anti-Hepatocyte Growth Factor Receptor (C-Met) Produced in Goat, Affinity Isolated Antibody
TYK2 Variants in B-Acute Lymphoblastic Leukaemia
Janus Kinases in Leukemia
Tyrosine Kinase Inhibitors for Solid Tumors in the Past 20 Years (2001–2020) Liling Huang†, Shiyu Jiang† and Yuankai Shi*
Novel Somatic Genetic Variants As Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients
Tyrosine Kinase 2 Immune Pathway Fact Sheet
Novel Tumor-Specific Mutations in Receptor Tyrosine Kinase Subdomain IX Significantly Reduce Extracellular Signal-Regulated Kinase Activity
Novel Roles of Erbb3 Receptor Tyrosine Kinase in Vesicular Trafficking
Comprehensive Analysis of Genes Involved in the Malignancy of Gastrointestinal Stromal Tumors
Top View
Flt3 Receptor Tyrosine Kinase in AML and Its Modulation of the P53/Hdm2/Bcl-2 Pathway
Loss of Tyrosine Kinase 2 Does Not Affect the Severity of Jak2v617f
Prognostic Value of ERBB4 Expression in Patients with Triple
Type I IFN Receptor-Signaling Complex Functions As a Scaffold
An Advanced Refractory Breast Cancer Patient with Human Epidermal Growth Factor Receptor 2 Discordance: a Case Report
Kinases That Are Currently Stored in the Phospho.ELM Database
The Role of Erbb3/HER3 in Gliomas and Breast Cancer: Molecular Mechanisms and Potential Role As Therapeutic Target
Molecular Network Pathway of ERBB in Diffuse-Type Gastric Cancer
Identification of an Indispensable Role for Tyrosine Kinase 2 in CTL-Mediated Tumor Surveillance
High-Throughput Functional Evaluation of Variants of Unknown
List of Actionable Genes and Potential Matched Therapy
Biomarker Testing 2020
(NRG1) Signaling Through Fyn Modulates NMDA Receptor Phosphorylation: Differential Synaptic Function in Nrg1ϩ/Ϫ Knock-Outs Compared with Wild-Type Mice
Two Common Disease-Associated TYK2 Variants Impact Exon Splicing and TYK2 Dosage
Medullary Thyroid Carcinoma Beyond Surgery: Advances, Challenges, and Perspectives
TYK2: an Upstream Kinase of Stats in Cancer
TYK2 in Cancer Metastases: Genomic and Proteomic Discovery
IL-10 Levels T Cells Reveals FLT3 As a Modulator of RNA Interference
Structure of the Pseudokinase–Kinase Domains from Protein Kinase TYK2 Reveals a Mechanism for Janus Kinase (JAK) Autoinhibition
Hotspot Mutations Detectable by Next-Generation Sequencing In
JAK Kinases in Health and Disease: an Update Arian Laurence1, Marko Pesu2,3, Olli Silvennoinen2,3 and John O’Shea*,1
Enzymatic Characterization of Wild-Type and Mutant Janus Kinase 1
Antisense Oligonucleotides Potent and Selective Knockdown Of
Downloaded from the Kaplan–Meier Plotter Website (
Mechanistic Insights Into Regulation of JAK2 Tyrosine Kinase
Development of the First Generation C-Met Kinase Inhibitors: Beginning of a Path to a New Treatment for Cancer
Phospho ERBB2 / HER2 Antibody Duo (Total, Py1221/1222)
C-KIT Tyrosine Kinase in the Pathogenesis and Therapy of Core-Binding Factor-Related Acute Myeloid Leukaemia (AML)
The Prognostic Significance of HER2 Overexpression in Non-Small Cell Lung Cancer
Analysis of the Proteasome-Autophagy Crosstalk Under Proteotoxic Stress Conditions in Acute Myeloid Leukemia Rosa Guadalupe Lopez Reyes
MERTK Inhibition: Potential As a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
Active Kinase Manual
Biomarker Testing
Protein Tyrosine Kinase/RTK
Janus Kinase Inhibitors Mechanisms of Action
Myeloid Innate Immunity Human Vapril2018